Yesterday, on March 5, 2019, the FDA approved the use of ketamine for treatment-resistant depression. The new drug Spravato is a nasal spray that will only be available at specialty pharmacies, clinics, and doctor’s offices. Patients are not allowed to take it home with them. Although access to Spravato is highly restricted and it can […]
Texas Addiction Treatment Centers
(512) 605-2955
